Literature DB >> 1109770

A clinicopathologic study of 92 cases of granulosa cell tumor of the ovary with special reference to the factors influencing prognosis.

H Fox, K Agrawal, F A Langley.   

Abstract

Ninety-two cases of granulosa cell tumor of the ovary have been studied. The clinical and pathologic data from this group were similar to that obtained in previous series. Because of the long natural history of many granulosa cell tumors, crude death rates over a relatively short period give little indication of the true malignant potential of these neoplasms and hence corrected survival rates were calculated; these show that, if no patient died from any other disease, approximately half of the women with this neoplasm would die, as a result of the tumor, within 20 years. Factors indicating a relatively poor survival rate were: age over 40 at the time of diagnosis, a presentation with abdominal symptoms, a palpable mass, a solid large tumor, bilateral tumors, extraovarian spread, and numerous mitotic figures in the tumor. It is suggested that all granulosa cell tumors should be considered as malignant and that the factors pointing to a poor prognosis are those indicating that a particular tumor has been diagnosed at a late stage in its natural history, either because it has been present for a long time or because it is highly malignant. There are no definite criteria for defining the prognosis in a case in which the tumor has been removed at any early stage in its natural life history.

Entities:  

Mesh:

Year:  1975        PMID: 1109770     DOI: 10.1002/1097-0142(197501)35:1<231::aid-cncr2820350128>3.0.co;2-o

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  32 in total

1.  [Diagnosis and differential diagnosis of granulosa cell tumor].

Authors:  D Schmidt; F Kommoss
Journal:  Pathologe       Date:  2007-05       Impact factor: 1.011

Review 2.  Ovarian tumors. A review.

Authors:  R E Scully
Journal:  Am J Pathol       Date:  1977-06       Impact factor: 4.307

3.  Mutant FOXL2C134W Hijacks SMAD4 and SMAD2/3 to Drive Adult Granulosa Cell Tumors.

Authors:  Stine E Weis-Banke; Mads Lerdrup; Daniela Kleine-Kohlbrecher; Faizaan Mohammad; Simone Sidoli; Ole N Jensen; Toshihiko Yanase; Tomoko Nakamura; Akira Iwase; Anthe Stylianou; Nadeem R Abu-Rustum; Carol Aghajanian; Robert Soslow; Arnaud Da Cruz Paula; Richard P Koche; Britta Weigelt; Jesper Christensen; Kristian Helin; Paul A C Cloos
Journal:  Cancer Res       Date:  2020-07-08       Impact factor: 12.701

Review 4.  Ovarian tumors with functioning manifestations.

Authors:  Fattaneh A Tavassoli
Journal:  Endocr Pathol       Date:  1994-09       Impact factor: 3.943

5.  Patterns of spread and recurrence of sex cord-stromal tumors of the ovary.

Authors:  Melissa M Thrall; Pamela Paley; Ellen Pizer; Rochelle Garcia; Barbara A Goff
Journal:  Gynecol Oncol       Date:  2011-04-09       Impact factor: 5.482

6.  Pure Large Cell Neuroendocrine Carcinoma of the Ovary with Metastasis to Cervix: A Rare Case Report and Review of Literature.

Authors:  Lakshmi Agarwal; Bhawna Gupta; Ayushi Jain
Journal:  J Clin Diagn Res       Date:  2016-09-01

7.  Granulosa Cell Tumors: Novel Predictors of Recurrence in Early-stage Patients.

Authors:  Sharif Sakr; Eman Abdulfatah; Sumi Thomas; Zaid Al-Wahab; Rafic Beydoun; Robert Morris; Rouba Ali-Fehmi; Sudeshna Bandyopadhyay
Journal:  Int J Gynecol Pathol       Date:  2017-05       Impact factor: 2.762

8.  FOXL2 molecular status in adult granulosa cell tumors of the ovary: A study of primary and metastatic cases.

Authors:  Gian Franco Zannoni; Giuseppina Improta; Marco Petrillo; Angela Pettinato; Giovanni Scambia; Filippo Fraggetta
Journal:  Oncol Lett       Date:  2016-06-14       Impact factor: 2.967

Review 9.  Presentation of two patients with malignant granulosa cell tumors, with a review of the literature.

Authors:  Ryousuke Tamura; Yoshihito Yokoyama; Takeshi Yanagita; Yukiko Matsumura; Kazuhiro Abe; Ryousuke Taniguchi; Hideki Mizunuma
Journal:  World J Surg Oncol       Date:  2012-09-11       Impact factor: 2.754

10.  The anti-Müllerian hormone type II receptor: insights into the binding domains recognized by a monoclonal antibody and the natural ligand.

Authors:  Imed Salhi; Sylvie Cambon-Roques; Isabelle Lamarre; Daniel Laune; Franck Molina; Martine Pugnière; Didier Pourquier; Marian Gutowski; Jean-Yves Picard; Françoise Xavier; André Pèlegrin; Isabelle Navarro-Teulon
Journal:  Biochem J       Date:  2004-05-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.